TREM-1 contributes to the expansion and instability of atherosclerotic plaques, which can be seen clinically as either coronary artery disease (CAD) or angina when the coronary is partially blocked or atherosclerotic myocardial infarction (AMI) when it is fully blocked. Here, TREM1 is linked to coronary artery disorder.